<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fchem.2018.00606</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>On the Inhibition Mechanism of Glutathione Transferase P1 by Piperlongumine. Insight From Theory</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Prejan&#x000F2;</surname> <given-names>Mario</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/577416/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Marino</surname> <given-names>Tiziana</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/431306/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Russo</surname> <given-names>Nino</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/203369/overview"/>
</contrib>
</contrib-group>
<aff><institution>Dipartimento di Chimica e Tecnologie Chimiche, Universit&#x000E0; della Calabria</institution>, <addr-line>Arcavacata di Rende</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Vicent Moliner, Universitat Jaume I, Spain</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Katarzyna Swiderek, Universitat Jaume I, Spain; Laura Masgrau, Universidad Aut&#x000F3;noma de Barcelona, Spain</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Tiziana Marino <email>tiziana.marino65&#x00040;unical.it</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Theoretical and Computational Chemistry, a section of the journal Frontiers in Chemistry</p></fn></author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>6</volume>
<elocation-id>606</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>09</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2018 Prejan&#x000F2;, Marino and Russo.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Prejan&#x000F2;, Marino and Russo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Piperlongumine (PL) is an anticancer compound whose activity is related to the inhibition of human glutathione transferase of pi class (GSTP1) overexpressed in cancerous tumors and implicated in the metabolism of electrophilic compounds. In the present work, the inhibition mechanism of hydrolyzed piperlongumine (hPL) has been investigated employing QM and QM/MM levels of theory. The potential energy surfaces (PESs) underline the contributions of Tyr residue close to <italic>G site</italic> in the catalytic pocket of the enzyme. The proposed mechanism occurs through a one-step process represented by the nucleophilic addition of the glutathione thiol to electrophilic species giving rise to the simultaneous C-S and H-C bonds formation. Both the used methods give barrier heights (19.8 and 21.5 kcal mol<sup>&#x02212;1</sup> at QM/MM and QM, respectively) close to that experimentally measured for the C-S bond formations (23.8 kcal mol<sup>&#x02212;1</sup>).</p></abstract>
<kwd-group>
<kwd>glutathione S-transferase</kwd>
<kwd>piperlongumine</kwd>
<kwd>hydrolysis mechanism</kwd>
<kwd>inhibition mechanism</kwd>
<kwd>MD DFT</kwd>
<kwd>QM</kwd>
<kwd>QMMM</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="1"/>
<ref-count count="73"/>
<page-count count="12"/>
<word-count count="6899"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Glutathione-S-transferases (GSTs) is a ubiquitous family of multifunctional enzymes of phase II detoxification system that conjugate reactive substrates with reduced tripeptide glutathione (GSH) in most cells, especially those in the liver and kidney (Hayes et al., <xref ref-type="bibr" rid="B27">2005</xref>; Oakley, <xref ref-type="bibr" rid="B47">2005</xref>; Stoddard et al., <xref ref-type="bibr" rid="B62">2017</xref>). In particular, they catalyze the nucleophilic attack of the thiol group arising from cysteine residue (Cys) of the GSH on electrophilic substrates leading to formation of conjugates, that are less toxic and more water-soluble than the parent species, facilitating their elimination from cells (Broxterman et al., <xref ref-type="bibr" rid="B14">1995</xref>; Townsend and Tew, <xref ref-type="bibr" rid="B65">2003</xref>; Wang et al., <xref ref-type="bibr" rid="B67">2017</xref>). Their role in protecting the cells from oxidative attack, in association with their overexpression in many cancer cells, makes them good candidates as cancer biomarkers (McIlwain et al., <xref ref-type="bibr" rid="B42">2006</xref>; Lo and Ali-Osman, <xref ref-type="bibr" rid="B38">2007</xref>). Furthermore, glutathione-S-transferases are associated with multidrug resistance of tumor cells and are involved in drug detoxification and in apoptosis control (Townsend and Tew, <xref ref-type="bibr" rid="B65">2003</xref>; Mejerman et al., <xref ref-type="bibr" rid="B43">2008</xref>). Mammalian cytosolic GSTs isoenzymes belong to different families or classes (alpha, mu, pi, theta, kappa, sigma, zeta, and omega) (Wilce and Parker, <xref ref-type="bibr" rid="B70">1994</xref>; Armstrong, <xref ref-type="bibr" rid="B8">1997</xref>; Sheehan et al., <xref ref-type="bibr" rid="B59">2001</xref>) based on their molecular masses, isoelectric points and other properties. Every isoenzyme subunit contains an active site entailing a binding site for the cofactor GSH (<italic>G-site</italic>) and one for the electrophilic substrate (<italic>H-site</italic>) (Dirr et al., <xref ref-type="bibr" rid="B15">1994</xref>; Wilce and Parker, <xref ref-type="bibr" rid="B70">1994</xref>). In particular, the Glutathione S-transferase P1 (GSTP1) is overexpressed in different human malignancies affecting important organs as lung, colon, stomach, kidney, ovary, mouth, and testis (Green et al., <xref ref-type="bibr" rid="B21">1993</xref>; Katagiri et al., <xref ref-type="bibr" rid="B34">1993</xref>; Grignon et al., <xref ref-type="bibr" rid="B22">1994</xref>; Okuyama et al., <xref ref-type="bibr" rid="B49">1994</xref>; Zhang et al., <xref ref-type="bibr" rid="B71">1994</xref>; Inoue et al., <xref ref-type="bibr" rid="B30">1995</xref>; Ruiz-Gomez et al., <xref ref-type="bibr" rid="B57">2000</xref>). This overexpression has been linked to acquire multidrug resistance to chemotherapeutic agents (cisplatin, chlorambucil, and ethacrynic acid) (Ban et al., <xref ref-type="bibr" rid="B9">1996</xref>; Oakley et al., <xref ref-type="bibr" rid="B48">1997</xref>; Mejerman et al., <xref ref-type="bibr" rid="B43">2008</xref>; Karpusas et al., <xref ref-type="bibr" rid="B33">2013</xref>; Pei et al., <xref ref-type="bibr" rid="B50">2013</xref>; Perperopoulou et al., <xref ref-type="bibr" rid="B52">2018</xref>). GSTP1 has additional role in maintaining the cellular redox state (Tew, <xref ref-type="bibr" rid="B64">2007</xref>) and &#x0201C;nonenzymatic&#x0201D; antiapoptotic activity through its interaction with the <italic>c-Jun</italic> NH<sub>2</sub>-terminal kinase (JNK), a key enzyme implicated into the apoptotic cascade (Adler et al., <xref ref-type="bibr" rid="B2">1999</xref>; Wang et al., <xref ref-type="bibr" rid="B69">2001</xref>). For these reasons, GSTP1 is considered as a promising target for inactivation in cancer treatment and numerous researchers have spent considerable effort to propose potent inhibitors of this enzyme (Bezerra et al., <xref ref-type="bibr" rid="B12">2007</xref>; Federici et al., <xref ref-type="bibr" rid="B18">2009</xref>; Raj et al., <xref ref-type="bibr" rid="B55">2011</xref>; Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>; Boskovic et al., <xref ref-type="bibr" rid="B13">2013</xref>; Liao et al., <xref ref-type="bibr" rid="B37">2016</xref>; Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>; Zou et al., <xref ref-type="bibr" rid="B73">2018</xref>). Among these, piperlongumine (PL) is a natural alkaloid isolated from <italic>Piper longum</italic> L. characterized by the presence of two &#x003B1;, &#x003B2;- unsaturated functionalities (see Figure <xref ref-type="fig" rid="F1">1</xref>) and recently has been reported as a promising anticancer molecule by targeting the stress response to ROS, inducing apoptosis (Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>; Boskovic et al., <xref ref-type="bibr" rid="B13">2013</xref>; Liao et al., <xref ref-type="bibr" rid="B37">2016</xref>; Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Chemical Species involved in the inhibition reaction of GSTP1.</p></caption>
<graphic xlink:href="fchem-06-00606-g0001.tif"/>
</fig>
<p>This molecule also represents a promising lead compound in the developing potent GSTP1 inhibitors stimulating the synthesis of a huge number of its structural analogs (Bezerra et al., <xref ref-type="bibr" rid="B12">2007</xref>; Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>; Boskovic et al., <xref ref-type="bibr" rid="B13">2013</xref>; Liao et al., <xref ref-type="bibr" rid="B37">2016</xref>; Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>; Stoddard et al., <xref ref-type="bibr" rid="B62">2017</xref>). PL acts as Michael acceptor because can undergo heteroconjugate addition with the peptide-like molecules including nucleophilic thiols of cysteine residues in irreversible or reversible fashion. From stable isotope labeling (Raj et al., <xref ref-type="bibr" rid="B55">2011</xref>) the anti-cancer effects of PL were related to the promotion of reactive oxygen species (ROS) and to the reduction of GSH cellular levels (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). PL contains a trimethoxyphenyl head and two reactive olefins moieties (C2-C3 and C7-C8) that revealed to be essential for differentiating the cellular activity (Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>). The C2-C3 bond is critical for toxicity, ROS elevation and protein S-glutathionylation while C7-C8 is not necessary for these activities and is believed to enhance the toxicity (Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>; Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). This means that the two present olefins can be identified as the minimum pharmacophore of PL so that their modifications can originate analogs with different biological response (Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>). Furthermore, it can act as GSTP1-cosubstrate in both displacement and addition reactions. In this case, GSH bound in the G site of GSTP1 is the target of the inhibitor (Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>; Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). Recently, the high resolution X-ray crystal structure of GSTP1 (PDB code 5J41) in complex with PL and GSH proposed as the inhibition occurs without GSTP1 covalent modification by PL but, rather unexpectedly, PL results to be hydrolyzed to a trimethoxycinnamic acid (TMCA) deprived of the C2-C3 olefin (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). This finding does not completely fit the behavior of PL toward other cysteine-containing peptides that react with the C2-C3 reactive bond <italic>in vitro</italic> conditions (Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>). Harshbarger et al. provided the first structural model for the interactions between PL, GSH and GSTP1 (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). From this study emerged that PL acts as a prodrug. In fact, after entrance in the cell it undergoes hydrolysis giving rise to the TMCA that in turns reacts with GSH, located in the G site of GSTP1, affording the hPL:GSH conjugate as product of the addition reaction and confirming that no covalent bond formation occurs between PL and GSTP1. Although the presence in the literature of many scientific works (Bezerra et al., <xref ref-type="bibr" rid="B12">2007</xref>; Federici et al., <xref ref-type="bibr" rid="B18">2009</xref>; Adams et al., <xref ref-type="bibr" rid="B1">2012</xref>; Boskovic et al., <xref ref-type="bibr" rid="B13">2013</xref>; Peng et al., <xref ref-type="bibr" rid="B51">2015</xref>; Liao et al., <xref ref-type="bibr" rid="B37">2016</xref>; Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>; Zou et al., <xref ref-type="bibr" rid="B73">2018</xref>) on the piperlongumine selective inhibition of tumor growth in different types of cancers, the molecular mechanism involved in PL mediated cancer cell death remains still poorly understood. With the aim to contribute to a better knowledge, at atomistic level, of the inhibition mechanism of GSH by the hydrolyzed product of PL into the GSTP1 enzyme, a theoretical investigation in the framework of density functional theory (DFT) was undertaken. In addition, a MD simulation of initial enzyme-inhibitor (EI) complex has been also performed.</p></sec>
<sec sec-type="methods" id="s2">
<title>Methodology</title>
<sec>
<title>Active Site</title>
<p>The enzyme structure includes two identical homodimers, with a total mass of 48 kDa. The active sites are located in the interfaces between the two domains. Each active site in turn consists of two sub-sites: the <italic>G site</italic>, where GSH is located, in proximity to the outer side of protein surface and in direct contact with solvent molecules, and the <italic>H site</italic>, where the electrophilic inhibitor can be accommodated (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). The interactions between GSH and hPL with different residues of the cavity of both sites were treated at quantum mechanical level in both QM and QM/MM calculations. In particular, the QM region includes: the Arg13 which is engaged in hydrogen bonds with the N-terminal portion of GSH and the carboxyl group of inhibitor, the Lys44 which is anchored to C-terminal part of GSH, the Tyr7 with its OH moiety oriented toward the S atom of GSH-cysteine in such a manner to establish H bond between them, and Tyr108 which is involved in &#x003C0;-&#x003C0; interaction with inhibitor aromatic ring. Finally, the QM portion, contains also the Ile104 since its crucial role in correctly orienting hPL (in <italic>H site</italic>) during the conjugation phase with GSH (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>). Due to the closeness of active site to the protein surface, several water molecules present in the catalytic cavity were considered in the QM/MM model. Starting from the available crystallographic structure of GSTP1 by <italic>Homo Sapiens</italic> (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>; PDB code 5J41, 1.19 &#x000C5; resolution), the preparation of the models (see Figure <xref ref-type="fig" rid="F2">2</xref>) is described by the following procedure.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>The two models used. The QM/MM model <bold>(A)</bold> includes the whole protein with the water molecules, the red box defines the QM region used in both cluster <bold>(B)</bold> and QM/MM calculations. The amino acid residues of the QM portion are shown with ball and sticks representation.</p></caption>
<graphic xlink:href="fchem-06-00606-g0002.tif"/>
</fig></sec>
<sec>
<title>MD Calculations</title>
<p>As first step of the work it was necessary to perform the C8<sub>hPL</sub>-S<sub>GSH</sub> bond cleavage and then to relax the enzyme:GSH:inhibitor supramolecular system at the molecular mechanics (MM) level of theory before starting the MD simulation because the used X-ray structure was related to the final product of the inhibition process. Furthermore, the presence of the inhibitor molecule of non-protein nature implied its optimization at HF/6-31G(d) level of theory in order to derive the parameters by Antechamber tool, as implemented in AMBER 16 package (AMBER 16, <xref ref-type="bibr" rid="B5">2016</xref>). Intramolecular Lennard-Jones parameters and atomic charges were obtained using, respectively, General Amber Force Field (GAFF) (Wang et al., <xref ref-type="bibr" rid="B68">2004</xref>) and Restrained Electrostatic potential (RESP) method (Bayly et al., <xref ref-type="bibr" rid="B10">1993</xref>). The obtained parameters of hPL are collected in Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
<p>The amber ff14SB (Maier et al., <xref ref-type="bibr" rid="B39">2015</xref>) force field was applied using the Xleap module and hydrogen atoms were added to the whole system. The protonation state of each amino acid has been assigned using the H&#x0002B;&#x0002B; web server (Gordon et al., <xref ref-type="bibr" rid="B20">2005</xref>; Myers et al., <xref ref-type="bibr" rid="B44">2006</xref>; Anandakrishnan et al., <xref ref-type="bibr" rid="B6">2012</xref>; <xref ref-type="bibr" rid="B25">H&#x0002B;&#x0002B; vesion 3.2</xref>, <xref ref-type="bibr" rid="B25">2016</xref>). A rectangular box (85 &#x000D7; 70 &#x000D7; 80&#x000C5;) was filled with TIP3P (Jorgensen et al., <xref ref-type="bibr" rid="B32">1983</xref>) water molecules within 12.0 &#x000C5; from the surface of the enzyme. The classical MD simulation was applied for 100 ps in NVT ensemble with a progressive heating phase, from 0 to 310 K. A final MD production of 20 ns was obtained in NPT ensemble (1 bar and 310 K). During the simulations, a cutoff radius for non-bonded interactions was fixed at 12 &#x000C5; and Particle Mesh Ewald summation method (PME) (Ewald, <xref ref-type="bibr" rid="B17">1921</xref>) and SHAKE algorithm (Ryckaert et al., <xref ref-type="bibr" rid="B58">1977</xref>) were employed to constrain the motion in H-including bonds, in order to use a 2 fs integration step The root-mean-square deviation (RMSD) analysis of the whole protein and the <italic>H</italic> and <italic>G</italic> active sites residues was performed to verify the stability of the system during the MD simulation (Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>). To better examine the conformational behavior of the inhibitor-protein system, a MD simulation has been also performed on the alone enzyme. The obtained root-mean-square fluctuation (RMSF) is shown in Figure <xref ref-type="supplementary-material" rid="SM1">S2</xref>. Furthermore, in order to verify conformational homogeneity for inhibitor binding modes in to the catalytic pocket, 20 structures were selected along MD simulation (Figure <xref ref-type="supplementary-material" rid="SM1">S3</xref>). Clustering results confirmed that the last frame, obtained at 20 ns, is a good representative configuration as to be adopted as starting configuration for creating QM cluster and QM/MM model.</p></sec>
<sec>
<title>QM Cluster and QMMM Models</title>
<p>The amino acids considered in the QM region (Tyr7, Arg13, Tyr103, Ile104, Lys44) were truncated as depicted in Figure <xref ref-type="fig" rid="F2">2</xref>. The missing hydrogens were added manually and one water molecule (lying at 3.601 &#x000C5; from the GSH) was explicitly considered, being implicated in direct interaction with nucleophilic agent while the other waters are located away than 4 &#x000C5;. The C atoms labeled with &#x0201C;<sup>&#x0002A;</sup>&#x0201D; were kept fixed during geometry optimizations, applying the locking scheme, to prevent artificial movements (Siegbahn and Himo, <xref ref-type="bibr" rid="B60">2011</xref>; Piazzetta et al., <xref ref-type="bibr" rid="B53">2015</xref>; Himo, <xref ref-type="bibr" rid="B28">2017</xref>). The QM cluster model was found to be adequate in the elucidation of the catalytic mechanism followed by other enzymes (Amata et al., <xref ref-type="bibr" rid="B4">2011</xref>; Lan and Chen, <xref ref-type="bibr" rid="B35">2016</xref>; Prejan&#x000F2; et al., <xref ref-type="bibr" rid="B54">2017</xref>). The obtained model consists of 136 atoms with a total charge equal to zero.</p>
<p>The QM/MM model was obtained applying the two layers ONIOM formalism (Svensson et al., <xref ref-type="bibr" rid="B63">1996</xref>) as implemented in Gaussian09 code (Frisch et al., <xref ref-type="bibr" rid="B19">2013</xref>), maintaining the same atoms mentioned in QM cluster model setup. The entire enzyme and a number of water molecules within 5 &#x000C5; from the catalytic site were considered (Figure <xref ref-type="fig" rid="F2">2</xref>). During the optimization, all the water molecules and residues out of 18 &#x000C5; sphere from the active site were kept frozen, applying the standard procedure for single conformation PES studies (Sousa et al., <xref ref-type="bibr" rid="B61">2017</xref>). The final model contains 7811 atoms.</p></sec>
<sec>
<title>Technical Details</title>
<p>Gaussian 09 (Frisch et al., <xref ref-type="bibr" rid="B19">2013</xref>) software package was used to perform calculations using B3LYP (Lee et al., <xref ref-type="bibr" rid="B36">1988</xref>; Becke, <xref ref-type="bibr" rid="B11">1993</xref>) hybrid functional in QM region of both used models. For S, N, H, O and C atoms, 6-31&#x0002B;G(d,p) basis set was used during the optimizations. Linear transit scans were performed, in order to detect stationary points along reaction coordinates. To confirm the nature of intermediates or transition states, frequencies calculation was performed at the same level of theory, for each stationary point intercepted along potential energy surface (PES). To obtain more accurate electronic energies single point calculations with 6-311&#x0002B;G(2d,2p) larger basis set were performed. The final energy profiles include the zero point energy (ZPE) and dispersion corrections (evaluated using the DFT-D3 procedure; Grimme et al., <xref ref-type="bibr" rid="B24">2011</xref>) and solvation energy.</p>
<p>The electrostatic embedding as implemented in Gaussian 09 was employed to evaluate the Coulomb interactions between MM and QM regions in all calculations (Vreven et al., <xref ref-type="bibr" rid="B66">2006</xref>). For the QM cluster calculations, single point calculations adopting the SCRF-SMD solvation model with a dielectric constant &#x003B5; &#x0003D; 4, simulating the enzyme environment, was used (Marenich et al., <xref ref-type="bibr" rid="B40">2009</xref>). The same level of theory was adopted during the optimizations of species involved in hydrolysis of PL, considering the dielectric constant of 78.0, as successfully proposed in other studies (Ritacco et al., <xref ref-type="bibr" rid="B56">2015</xref>; Marino et al., <xref ref-type="bibr" rid="B41">2016</xref>). NBO (NBO version 3.1, <xref ref-type="bibr" rid="B45">2001</xref>) and non-covalent interaction (NCI) (NCIPLOT, version 3.0, <xref ref-type="bibr" rid="B46">2011</xref>) analyses were performed on all the stationary points of the investigated PESs at both QM and QM/MM levels.</p>
<p>As far as the proton affinity calculations for establishing the oxygen carbonyl to be considered in the hydrolysis mechanism at acidic conditions, the proton affinities as binding energies (BE) have been estimated as indicated by the following expression:</p>
<disp-formula id="E1"><mml:math id="M1"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mtext>BE</mml:mtext><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mo>&#x00394;</mml:mo><mml:msub><mml:mrow><mml:mtext>H</mml:mtext></mml:mrow><mml:mrow><mml:mtext>hPL</mml:mtext><mml:mo>-</mml:mo><mml:mtext>H</mml:mtext><mml:mo>&#x0002B;</mml:mo></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mo>&#x00394;</mml:mo><mml:msub><mml:mrow><mml:mtext>H</mml:mtext></mml:mrow><mml:mrow><mml:mtext>hPL</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
<p>The BE is calculated as the difference between the enthalpy of the protonated system and that of the neutral one. In the calculations, the H<sup>&#x0002B;</sup> contribution does not appear since we evaluated the energetic difference, therefore the obtained binding energies represent the energy involved in the formation of the protonated systems.</p></sec></sec>
<sec id="s3">
<title>Results and Discussion</title>
<sec>
<title>Hydrolysis of Piperlongumine</title>
<p>Following the recent experimental indications that demonstrate as the PL suffers hydrolysis out of the enzyme pocket, (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>) we firstly study this process in aqueous media. The considered reaction mechanism is illustrated in Figure <xref ref-type="fig" rid="F3">3</xref>. As from the experimental evidence, (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>) we considered the hydrolysis mechanism of PL to occur on the oxygen of the carbonyl (C6) functionality next to C7-C8 olefin, under both neutral and acidic conditions to take into account the different intracellular pH conditions, since the acid pH values are observed in cancer cells (Townsend and Tew, <xref ref-type="bibr" rid="B65">2003</xref>; Wang et al., <xref ref-type="bibr" rid="B67">2017</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Hydrolysis mechanism of PL in neutral (bold line) and acidic conditions (dashed line).</p></caption>
<graphic xlink:href="fchem-06-00606-g0003.tif"/>
</fig>
<p>On the contrary, our computed BE shows that the carbonyl moiety next to C2-C3 olefin has minor proton affinity (about 4 kcal mol<sup>&#x02212;1</sup>) with respect to that next to C7-C8 one, indicating as under the same conditions the favored protonation site is the oxygen of C6.</p>
<p>The optimized geometries of the stationary points are reported in (Figures S4, S5), while the calculated energy profiles are depicted in Figure <xref ref-type="fig" rid="F4">4</xref>. As shown from Figure <xref ref-type="fig" rid="F3">3</xref>, we propose at acid pH a mechanism occurring in a multistep process contrary to that at neutral conditions occurring in only one step. In both cases the product is the hPL, while the leaving group is 1,2,5,6-tetra-hydro-pyridin-2-ol (t-PyrOH) neutral and protonated, respectively. For clarity, in the text the remaining double bond in the hPL upon hydrolysis will retain the same numeration than in PL, (C7-C8). The processes are exothermic although at pH acid the exoergonicity is more pronounced (Figure <xref ref-type="fig" rid="F4">4</xref>). From our results, the acidic hydrolysis is strongly favored as suggested by lower activation barriers (by about 10 kcal mol<sup>&#x02212;1</sup>) than that found at neutral pH (see Figure <xref ref-type="fig" rid="F4">4</xref>). The calculated barrier in acidic environment well-agrees with those characterizing other anticancer molecules acting as prodrug (Alberto and Russo, <xref ref-type="bibr" rid="B3">2011</xref>; Ritacco et al., <xref ref-type="bibr" rid="B56">2015</xref>; Marino et al., <xref ref-type="bibr" rid="B41">2016</xref>). Once the hydrolyzed product is formed, the process of GSH-conjugation favored by GSTP1 starts through the attack to the C7-C8 double bond.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>B3LYP-D3/6-311&#x0002B;G(2d,2p)//B3LYP/6-31&#x0002B;G(d,p) (SMD,&#x003B5; &#x0003D; 78) energy profiles of PL hydrolysis in neutral conditions (blue line) and acid conditions (red line). The final energies contain ZPE and D3 corrections.</p></caption>
<graphic xlink:href="fchem-06-00606-g0004.tif"/>
</fig></sec>
<sec>
<title>GSTP1 Inhibition</title>
<p>To underline the role of GSTP1 during the inhibition process by hPL, we have considered, at both QM and QM/MM levels, two different reaction mechanisms (<bold>A</bold>, and <bold>B</bold>) as presented in Figure <xref ref-type="fig" rid="F5">5</xref>. In particular: (<bold>A</bold>) describes the nucleophile addition to the double bond of inhibitor by -SH group of GSH without involving any amino acid residue while path (<bold>B</bold>) takes into account the participation of the Tyr7 residue in the formation of the covalent adduct. In all the cases, the inhibition reaction occurs in a one-step process by the Michael addition of the thiol from GSH at the C7-C8 olefin of hPL. In all the considered mechanisms, the starting species is the ternary enzyme-hydrolyzed inhibitor-GSH complex (<bold>EI</bold>) obtained after the geometry optimization of the frame isolated by the previous MD cycle at 20 ns. From Figure <xref ref-type="fig" rid="F6">6</xref>, that illustrates the superposition of the crystallographic structure with the last MD snapshot, it is possible to note that hPL interacts with the binding cleft of the <italic>H site</italic> and no water molecules are close to the reaction center, in agreement with the hydrophobic nature of site (Tyr7, Tyr108, and Ile104 residues). As expected, the crystallographic pose (obtained with the reaction product) deviates in this moiety (see Figure <xref ref-type="fig" rid="F6">6</xref>). At the contrary, the GSH region is well-superimposed confirming that this molecule is well-positioned with a correct orientation of the thiol.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Proposed mechanisms for GSTP1 inhibition by hPL.</p></caption>
<graphic xlink:href="fchem-06-00606-g0005.tif"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Superposition of the ternary adduct (EI) from MD (violet) with the X-ray structure (yellow) related to the P S-conjugate product.</p></caption>
<graphic xlink:href="fchem-06-00606-g0006.tif"/>
</fig>
<p>The energy profiles obtained employing QM and QM/MM tools for the two considered mechanisms, are reported in Figure <xref ref-type="fig" rid="F7">7</xref>. The reported QMMM energy values do not include the entropic contribution. In order to quantify this the Grimme procedure has been employed (Grimme, <xref ref-type="bibr" rid="B23">2012</xref>). Results (see Table <xref ref-type="supplementary-material" rid="SM1">S2</xref>) evidence that the T&#x00394;S terms slightly affect the previously obtained energy values. QM/MM structures of the initial complex (<bold>EI</bold>), the final S-conjugated product (<bold>P</bold>) and that of the transition states are reported in Figure <xref ref-type="fig" rid="F8">8</xref>. All the QM optimized geometries are given in (Figure <xref ref-type="supplementary-material" rid="SM1">S6</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>/B3LYP-D3/6-311&#x0002B;G(2d,2p)//B3LYP/6-31&#x0002B;G(d,p) (SMD,&#x003B5; &#x0003D; 4) (top) and B3LYP-D3/6-311&#x0002B;G(2d,2p):ff99SB//B3LYP/6-31&#x0002B;G(d,p):ff99SB (bottom) energy profiles of GSTP1 inhibition process by hPL for (A,B) mechanisms. In the black window are depicted the energy profile related to the reaction unassisted by the enzyme. The final energies contain ZPE and D3 corrections.</p></caption>
<graphic xlink:href="fchem-06-00606-g0007.tif"/>
</fig>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>B3LYP/6-31&#x0002B;G(d,p):ff99SB optimized geometries of EI, P, TSA, TSB. For the transition states the imaginary frequencies are reported.</p></caption>
<graphic xlink:href="fchem-06-00606-g0008.tif"/>
</fig>
<p>In <bold>EI</bold> the carboxylate moiety of the hPL is oriented in such a way to establish hydrogen bonds with Tyr7 (1.599 &#x000C5;) and SH group of GSH (2.138 &#x000C5;). Furthermore, van der Waals and hydrophobic interactions, such as those between the inhibitor and the Ile104 and Arg14 residues (see Figure <xref ref-type="fig" rid="F8">8</xref>) contribute to optimally accommodate the inhibitor into the H binding site. In fact, now the key reacting atoms, C8 of the hPL and SH nucleophile species, are placed in suitable way (at 4.271 &#x000C5;) to allow the deactivation reaction. In path <bold>A</bold> the intercepted transition state (<bold>TSA</bold>) represents a four-centered structure where the sulfur addition to the C8 (1.880 &#x000C5;) and the C7-H bond formation (1.467 &#x000C5;) simultaneously occur. The corresponding frequency analysis confirms a first-order saddle point with an imaginary frequency (1510<italic>i</italic> cm<sup>&#x02212;1</sup>) which corresponds to a vibrational mode involving a strong C7&#x02013;H coupling and a relatively weaker C8&#x02013;S one. The C8-S bond is already established and the forming C-H one can be evinced by the elongation of the C7-C8 bond (1.544 &#x000C5;). This barrier results to be 64.4 kcal mol<sup>&#x02212;1</sup> at QM/MM level and 70.9 kcal mol<sup>&#x02212;1</sup> at QM one. Both values are very close to that computed for the reaction unassisted by the catalyst (76.0 kcal mol<sup>&#x02212;1</sup>, see Figure <xref ref-type="fig" rid="F7">7</xref>). The resulting product (<bold>P</bold>), shown in Figure <xref ref-type="fig" rid="F8">8</xref>, evidences that the C-S bond is formed (1.818 &#x000C5;) and the C8-C7 is elongated (1.532 &#x000C5;) confirming the occurred sp<sup>3</sup> hybridization of the two involved carbon atoms. The exothermicity is evaluated to be 10.8 kcal mol<sup>&#x02212;1</sup> (5.8 kcal mol<sup>&#x02212;1</sup> in the QM cluster). The mechanism <bold>B</bold> (Figure <xref ref-type="fig" rid="F5">5</xref>) involves the participation of the Tyr7 residue. In Figure <xref ref-type="fig" rid="F8">8</xref> is reported the optimized structure of the <bold>TSB</bold> connecting the <bold>EI</bold> and the covalent final complex (<bold>P</bold>). The nucleophilic attack to C8 occurs by GSH-thiolate (1.914 &#x000C5;) since the hydrogen of the S-H<sub>GSH</sub> group (2.019 &#x000C5;) has been delivered to oxygen (O<sub>Tyr</sub>) of the side chain of Tyr7 (1.090 &#x000C5;). In fact, the OH group of Tyr7, oriented via hydrogen bonding to carboxylate moiety of the inhibitor (1.599 &#x000C5;), in the TS becomes 1.310 &#x000C5; and points toward C7 atom for delivering its hydrogen atom (O-H and H-C7 distances are found to be 1.310 and 1.174 &#x000C5;, respectively) while the C7-C8 bond is elongated (1.535 &#x000C5;) (see Figure <xref ref-type="fig" rid="F8">8)</xref>. The TS located along the mechanism <bold>B</bold> lies at 21.5 kcal mol<sup>&#x02212;1</sup> (QM) and 19.8 kcal mol<sup>&#x02212;1</sup> (QM/MM) above the <bold>EI</bold>. Both values are very close to the available experimental one (23.8 kcal mol<sup>&#x02212;1</sup>) concerning the C-S bond formation (Huskey et al., <xref ref-type="bibr" rid="B29">1991</xref>). The superposition of our optimized glutathionil-conjugated product <bold>P</bold> with the corresponding crystallographic structure (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>; see Figure <xref ref-type="fig" rid="F9">9</xref>) reveals a good RMSD value in both GSH and <italic>H site</italic> regions. The exothermicity 10.8 kcal mol<sup>&#x02212;1</sup> means that the reverse reaction can be accessible but much slower also for the high barrier required in the reverse process <bold>P EI</bold> (30.6 kcal mol<sup>&#x02212;1</sup>). <bold>TSB</bold> evidence as the formation of the S-C8 bond is strictly related to the deprotonation of the SH moiety of GSH at the expense of the Tyr7 acting as proton shuttle with a consequent reduction of barrier (19.8 kcal mol<sup>&#x02212;1</sup>).</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p>Superposition of the ONIOM optimized structure of the final hPL:GSH conjugated product (violet) with its corresponding crystallographic structure characterized (yellow).</p></caption>
<graphic xlink:href="fchem-06-00606-g0009.tif"/>
</fig>
<p>This is in agreement with previous works on other GST enzymes (Zheng and Ornstein, <xref ref-type="bibr" rid="B72">1997</xref>; Angelucci et al., <xref ref-type="bibr" rid="B7">2005</xref>; Dourado et al., <xref ref-type="bibr" rid="B16">2008</xref>) revealing the importance of the acidic properties of a Tyr during the catalysis of glutathione-S-Transferase. Furthermore, our findings corroborate the hypothesis advanced by the previous structural analysis (Harshbarger et al., <xref ref-type="bibr" rid="B26">2017</xref>) revealing as no covalent bond formation between hPL and GSPT1 was observed and that PL acts as prodrug. With the aim to evaluate the nature of the interactions present inside the catalytic pocket during the process, in Figure <xref ref-type="fig" rid="F10">10</xref> we have reported the density of isosurfaces arising from NCI analysis, indicating the different contributions of the residues retained in the QM region.</p>
<fig id="F10" position="float">
<label>Figure 10</label>
<caption><p>Nonbonding interaction plot calculated for the stationary points at B3LYP-D3/6-311&#x0002B;G(2d,2p)//B3LYP/6-31&#x0002B;G(d,p) level for the B mechanism. The red circle defines the portion where the bonds breaking and formation occur.</p></caption>
<graphic xlink:href="fchem-06-00606-g0010.tif"/>
</fig>
<p>In every characterized stationary point, it can be noted the salt bridges occurring between the side-chains of Lys44 and Arg13 with the carboxyl moiety of carboxyl- and amino-terminal of GSH (blue region indicates strong attractive interactions while the red isosurfaces account for the repulsive interactions related to the center of &#x003C0; systems of Tyr7 and Tyr108 and the inhibitor molecule, as usually for aromatic systems strong non-bonded overlap is indicated (Johnson et al., <xref ref-type="bibr" rid="B31">2010</xref>). Further information arises from the green regions indicative of the van der Waals forces characterizing the cavity containing the inhibitor molecule and identified by the hydrophobic residues Tyr108 and Ile104. It is interesting to underline as the interaction involving the Ile104 becomes more intense as the reaction proceeds. At the contrary no relevant contributions arise from the NBO analysis (see Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>) except for a little bit increased nucleophile nature of the sulfur atom of GSH in the enzyme and a decreased negative charge on the C7-C8 bond of the hPL species with the respect to the corresponding values obtained for the process unassisted by enzyme. In the <bold>TSB</bold> species, a more attractive interaction appears in proximity of the region interested in the chemical events (circled in red in Figure <xref ref-type="fig" rid="F10">10</xref>) symptomatic of the occurring S-C8 bond formation. Furthermore, the interatomic distances, during the mechanism, between the residues of the QM region and the GSH and hPL species, reported in Table <xref ref-type="supplementary-material" rid="SM1">S4</xref>, highlight how no significant change occurs in the catalytic pocket.</p></sec></sec>
<sec sec-type="conclusions" id="s4">
<title>Conclusion</title>
<p>This study focuses on the inhibition mechanism of the glutathione-S-transferase Pi 1 by the hydrolyzed product of piperlongumine. We propose the mechanism following the most recent experimental evidences taking into account in particular the role of Tyr7 on the complex formation between the glutathione and the inhibitor inside the catalytic pocket of enzyme.</p>
<p>The hydrolysis of PL for giving hPL has been considered in neutral and acid conditions. The last <bold>one</bold> provided the better energetic path.</p>
<p>The agreement between cluster QM and the more computational demanding hybrid QM/MM methods is quite good. Structural and energetic computed properties are in line with the available experimental data.</p>
<p>The lowest energy reaction mechanism for reaction of hPL with GSH corresponds to that in which the Tyr7 residue is involved in the inhibition reaction deprotonating the GSH and donates the proton, in a concerted fashion, to the C7 substrate atom. The computed barrier heights result 19.8 and 21.5 kcal mol<sup>&#x02212;1</sup> in both QM/MM and QM models, respectively. Both computations clearly indicate the same reaction mechanism by TSB as the preferred one with difference in the barrier eight is of only 1.7 kcal mol<sup>&#x02212;1</sup>and propose an exergonic reaction.</p>
<p>We hope that the obtained new insights on the reaction mechanism of human GSTP1 inhibition with natural piperlongumine substrate can be useful in the design of new selective and more potent inhibitors.</p></sec>
<sec id="s5">
<title>Author Contributions</title>
<p>MP, TM, and NR have analyzed the results, edit, and reviewed equally the manuscript. MP, TM, and NR approved it for publications.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer KS and handling Editor declared their shared affiliation.</p></sec></sec>
</body>
<back>
<sec sec-type="supplementary-material" id="s6">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2018.00606/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2018.00606/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>D. J.</given-names></name> <name><surname>Dai</surname> <given-names>M. G.</given-names></name> <name><surname>Pellegrino</surname> <given-names>G.</given-names></name> <name><surname>Wagner</surname> <given-names>B. K.</given-names></name> <name><surname>Stern</surname> <given-names>A. M.</given-names></name> <name><surname>Shamji</surname> <given-names>A. F.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs</article-title>. <source>PNAS</source> <volume>109</volume>, <fpage>15115</fpage>&#x02013;<lpage>15120</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1212802109</pub-id><pub-id pub-id-type="pmid">22949699</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname> <given-names>V.</given-names></name> <name><surname>Yin</surname> <given-names>Z.</given-names></name> <name><surname>Fuchs</surname> <given-names>S. Y.</given-names></name> <name><surname>Benezra</surname> <given-names>M.</given-names></name> <name><surname>Rosario</surname> <given-names>L.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Regulation of JNK signaling by GSTp</article-title>. <source>EMBO J.</source> <volume>18</volume>, <fpage>1321</fpage>&#x02013;<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/18.5.1321</pub-id><pub-id pub-id-type="pmid">10064598</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alberto</surname> <given-names>M. E.</given-names></name> <name><surname>Russo</surname> <given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Methionine ligand selectively promotes monofunctional adducts between trans-EE platinum anticancer drug and guanine DNA base</article-title>. <source>Chem. Commun.</source> <volume>47</volume>, <fpage>887</fpage>&#x02013;<lpage>889</lpage>. <pub-id pub-id-type="doi">10.1039/C0CC03605F</pub-id><pub-id pub-id-type="pmid">21069245</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amata</surname> <given-names>O.</given-names></name> <name><surname>Marino</surname> <given-names>T.</given-names></name> <name><surname>Russo</surname> <given-names>N.</given-names></name> <name><surname>Toscano</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Catalytic activity of a &#x003B6;-class zinc and cadmium containing carbonic anhydrase</article-title>. <source>Compared work mechanisms. Phys. Chem. Chem. Phys.</source> <volume>13</volume>, <fpage>3468</fpage>&#x02013;<lpage>3477</lpage>. <pub-id pub-id-type="doi">10.1039/C0CP01053G</pub-id><pub-id pub-id-type="pmid">21212893</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="book"><person-group person-group-type="author"><collab>AMBER 16</collab></person-group> (<year>2016</year>). <publisher-name>University of California</publisher-name>, <publisher-loc>San Francisco, CA</publisher-loc>.</citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anandakrishnan</surname> <given-names>R.</given-names></name> <name><surname>Aguilar</surname> <given-names>B.</given-names></name> <name><surname>Onufriev</surname> <given-names>A. V.</given-names></name></person-group> (<year>2012</year>). <article-title>H&#x0002B;&#x0002B; 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations</article-title>. <source>Nucleic Acids Res.</source> <volume>40</volume>, <fpage>W537</fpage>&#x02013;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks375</pub-id><pub-id pub-id-type="pmid">22570416</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Angelucci</surname> <given-names>F.</given-names></name> <name><surname>Baiocco</surname> <given-names>P.</given-names></name> <name><surname>Brunori</surname> <given-names>M.</given-names></name> <name><surname>Gourlay</surname> <given-names>L.</given-names></name> <name><surname>Morea</surname> <given-names>V.</given-names></name> <name><surname>Bellelli</surname> <given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Insights into the catalytic mechanism of glutathione s-transferase: the lesson from schistosoma haematobium</article-title>. <source>Structure</source> <volume>13</volume>, <fpage>1241</fpage>&#x02013;<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2005.06.007</pub-id><pub-id pub-id-type="pmid">16154081</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname> <given-names>R. N.</given-names></name></person-group> (<year>1997</year>). <article-title>Structure, catalytic mechanism, and evolution of the glutathione transferases</article-title>. <source>Chem. Res. Toxicol.</source> <volume>10</volume>, <fpage>2</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1021/tx960072x</pub-id><pub-id pub-id-type="pmid">9074797</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ban</surname> <given-names>N.</given-names></name> <name><surname>Takahashi</surname> <given-names>Y.</given-names></name> <name><surname>Takayama</surname> <given-names>T.</given-names></name> <name><surname>Kura</surname> <given-names>T.</given-names></name> <name><surname>Katahira</surname> <given-names>T.</given-names></name> <name><surname>Sakamaki</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>1996</year>). <article-title>Transfection of Glutathione S-Transferase (GST)-&#x003C0; Antisense Complementary DNA Increases the Sensitivity of a Colon Cancer Cell Line to Adriamycin, Cisplatin, Melphalan, and Etoposide</article-title>. <source>Cancer Res.</source> <volume>56</volume>, <fpage>3577</fpage>&#x02013;<lpage>3582</lpage>. <pub-id pub-id-type="pmid">8758929</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bayly</surname> <given-names>C. I.</given-names></name> <name><surname>Cieplak</surname> <given-names>P.</given-names></name> <name><surname>Cornell</surname> <given-names>W. D.</given-names></name> <name><surname>Kollman</surname> <given-names>P. A.</given-names></name></person-group> (<year>1993</year>). <article-title>A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model</article-title>. <source>J. Phys. Chem.</source> <volume>97</volume>, <fpage>10269</fpage>&#x02013;<lpage>10280</lpage>. <pub-id pub-id-type="doi">10.1021/j100142a004</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becke</surname> <given-names>A. D.</given-names></name></person-group> (<year>1993</year>). <article-title>Density-functional thermochemistry. <italic>III</italic>. The role of exact exchange</article-title>. <source>J. Chem. Phys.</source> <volume>98</volume>, <fpage>5648</fpage>&#x02013;<lpage>5652</lpage>. <pub-id pub-id-type="doi">10.1063/1.464913</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname> <given-names>D. P.</given-names></name> <name><surname>Milit&#x000E3;o</surname> <given-names>G. C.</given-names></name> <name><surname>de Castro</surname> <given-names>F. O.</given-names></name> <name><surname>Pessoa</surname> <given-names>C.</given-names></name> <name><surname>de Moraes</surname> <given-names>M. O.</given-names></name> <name><surname>Silveira</surname> <given-names>E. R.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways</article-title>. <source>Toxicol. in vitro</source>, <volume>21</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2006.07.007</pub-id><pub-id pub-id-type="pmid">16971088</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boskovic</surname> <given-names>Z. V.</given-names></name> <name><surname>Hussain</surname> <given-names>M. M.</given-names></name> <name><surname>Drew</surname> <given-names>J. A.</given-names></name> <name><surname>Mingji</surname> <given-names>D.</given-names></name> <name><surname>Schreiber</surname> <given-names>S. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Synthesis of piperlogs and analysis of their effects on cells</article-title>. <source>Tetrahedron</source> <volume>69</volume>, <fpage>7559</fpage>&#x02013;<lpage>7567</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2013.05.080</pub-id><pub-id pub-id-type="pmid">24273350</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broxterman</surname> <given-names>H. J.</given-names></name> <name><surname>Giaccone</surname> <given-names>G.</given-names></name> <name><surname>Lankelma</surname> <given-names>J.</given-names></name></person-group> (<year>1995</year>). <article-title>Multidrug resistance proteins and other drug transport-related resistance to natural product agents</article-title>. <source>Curr. Opin. Oncol.</source> <volume>7</volume>, <fpage>532</fpage>&#x02013;<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1097/00001622-199511000-0001</pub-id><pub-id pub-id-type="pmid">8547402</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dirr</surname> <given-names>H.</given-names></name> <name><surname>Reinemer</surname> <given-names>P.</given-names></name> <name><surname>Huber</surname> <given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function</article-title>. <source>Eur. J. Biochem.</source> <volume>220</volume>, <fpage>645</fpage>&#x02013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1994.tb18666.x</pub-id><pub-id pub-id-type="pmid">8143720</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dourado</surname> <given-names>D. F. A. R.</given-names></name> <name><surname>Fernandes</surname> <given-names>P. A.</given-names></name> <name><surname>Mannervik</surname> <given-names>B.</given-names></name> <name><surname>Ramos</surname> <given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Glutathione transferase: new model for glutathione activation</article-title>. <source>Chem. Eur. J.</source> <volume>14</volume>, <fpage>9591</fpage>&#x02013;<lpage>9598</lpage>. <pub-id pub-id-type="doi">10.1002/chem.200800946.</pub-id><pub-id pub-id-type="pmid">18792041</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewald</surname> <given-names>P. P.</given-names></name></person-group> (<year>1921</year>). <article-title>Die Berechnung optischer und elektrostatischer Gitterpotentiale</article-title>. <source>Ann. Phys-Berlin</source> <volume>64</volume>, <fpage>253</fpage>&#x02013;<lpage>287</lpage>.</citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Federici</surname> <given-names>L.</given-names></name> <name><surname>Lo Sterzo</surname> <given-names>C.</given-names></name> <name><surname>Pezzola</surname> <given-names>S.</given-names></name> <name><surname>Di Matteo</surname> <given-names>A.</given-names></name> <name><surname>Scaloni</surname> <given-names>F.</given-names></name> <name><surname>Federici</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases</article-title>. <source>Cancer Res.</source> <volume>69</volume>, <fpage>8025</fpage>&#x02013;<lpage>8034</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-1314</pub-id><pub-id pub-id-type="pmid">19808963</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Frisch</surname> <given-names>M. J.</given-names></name> <name><surname>Trucks</surname> <given-names>G. W.</given-names></name> <name><surname>Schlegel</surname> <given-names>H. B.</given-names></name> <name><surname>Scuseria</surname> <given-names>G. E.</given-names></name> <name><surname>Robb</surname> <given-names>M. A.</given-names></name> <name><surname>Cheeseman</surname> <given-names>J. R.</given-names></name> <etal/></person-group>. (<year>2013</year>). <source>Gaussian 09, Revision D.01.</source> <publisher-loc>Wallingford, CT</publisher-loc>: <publisher-name>Gaussian, Inc</publisher-name>.</citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>J. C.</given-names></name> <name><surname>Myers</surname> <given-names>J. B.</given-names></name> <name><surname>Folta</surname> <given-names>T. M.</given-names></name> <name><surname>Shoja</surname> <given-names>V.</given-names></name> <name><surname>Heath</surname> <given-names>L. S.</given-names></name> <name><surname>Onufriev</surname> <given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>H&#x0002B;&#x0002B;: a server for estimating p Ka s and adding missing hydrogens to macromolecules</article-title>. <source>Nucleic Acids Res.</source> <volume>33</volume>,<fpage>W368</fpage>&#x02013;<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki464</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname> <given-names>J. A.</given-names></name> <name><surname>Robertson</surname> <given-names>L. J.</given-names></name> <name><surname>Clark</surname> <given-names>A. H.</given-names></name></person-group> (<year>1993</year>). <article-title>S-transferase expression in benign and malignant ovarian tumours</article-title>. <source>Br. J. Cancer</source> <volume>68</volume>, <fpage>235</fpage>&#x02013;<lpage>239</lpage>. <pub-id pub-id-type="pmid">8347477</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grignon</surname> <given-names>D. J.</given-names></name> <name><surname>Abdel-Malak</surname> <given-names>M.</given-names></name> <name><surname>Mertens</surname> <given-names>W. C.</given-names></name> <name><surname>Sakr</surname> <given-names>W. A.</given-names></name> <name><surname>Shepherd</surname> <given-names>R. R.</given-names></name></person-group> (<year>1994</year>). <article-title>Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation</article-title>. <source>Mod. Pathol.</source> <volume>7</volume>, <fpage>186</fpage>&#x02013;<lpage>189</lpage>. <pub-id pub-id-type="pmid">8008741</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimme</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>), <article-title>Supramolecular binding thermodynamics by dispersion-corrected density functional theory</article-title>. <source>Chem. Eur. J.</source><volume>18</volume>, <fpage>9955</fpage>&#x02013;<lpage>9964</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201200497.</pub-id><pub-id pub-id-type="pmid">22782805</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimme</surname> <given-names>S.</given-names></name> <name><surname>Ehrlich</surname> <given-names>S.</given-names></name> <name><surname>Goerigk</surname> <given-names>L</given-names></name></person-group> (<year>2011</year>). <article-title>Effect of the damping function in dispersion corrected density functional theory</article-title>. <source>J. Comput. Chem.</source> <volume>32</volume>, <fpage>1456</fpage>&#x02013;<lpage>1465</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21759</pub-id><pub-id pub-id-type="pmid">21370243</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="web"><person-group person-group-type="author"><collab>H&#x0002B;&#x0002B; vesion 3.2</collab></person-group> (<year>2016</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="http://biophysics.cs.vt.edu/H&#x0002B;&#x0002B;">http://biophysics.cs.vt.edu/H&#x0002B;&#x0002B;</ext-link></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harshbarger</surname> <given-names>W.</given-names></name> <name><surname>Gondi</surname> <given-names>S.</given-names></name> <name><surname>Ficarro</surname> <given-names>S. B.</given-names></name> <name><surname>Hunter</surname> <given-names>J.</given-names></name> <name><surname>Udayakumar</surname> <given-names>D.</given-names></name> <name><surname>Gurbani</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Structural and biochemical analyses reveal the mechanism of glutathione S-transferase Pi 1 inhibition by the anti-cancer compound piperlongumine</article-title>. <source>J. Biol. Chem.</source> <volume>292</volume>, <fpage>112</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.750299</pub-id><pub-id pub-id-type="pmid">27872191</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname> <given-names>J. D.</given-names></name> <name><surname>Flanagan</surname> <given-names>J. U.</given-names></name> <name><surname>Jowsey</surname> <given-names>I. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Glutathione transferases</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source> <volume>45</volume>, <fpage>51</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.45.120403.095857</pub-id><pub-id pub-id-type="pmid">15822171</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Himo</surname> <given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Recent trends in quantum chemical modeling of enzymatic reactions</article-title>. <source>J. Am. Chem. Soc.</source><volume>139</volume>, <fpage>6780</fpage>&#x02013;<lpage>6786</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b02671</pub-id><pub-id pub-id-type="pmid">28493715</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huskey</surname> <given-names>S. E. W.</given-names></name> <name><surname>Phillip Huskey</surname> <given-names>W.</given-names></name> <name><surname>Lu</surname> <given-names>A. Y. H.</given-names></name></person-group> (<year>1991</year>). <article-title>Contributions of thiolate &#x0201C;desolvation&#x0201D; to catalysis by glutathione S-transferase isozymes 1-1 and 2-2: evidence from kinetic solvent isotope effects</article-title>. <source>J. Am. Chem. Soc.</source> <volume>113</volume>, <fpage>2283</fpage>&#x02013;<lpage>2290</lpage>. <pub-id pub-id-type="doi">10.1021/ja00006a056</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname> <given-names>T.</given-names></name> <name><surname>Ishida</surname> <given-names>T.</given-names></name> <name><surname>Sugio</surname> <given-names>K.</given-names></name> <name><surname>Maehara</surname> <given-names>Y.</given-names></name> <name><surname>Sugimachi</surname> <given-names>K.</given-names></name></person-group> (<year>1995</year>). <article-title>Glutathione S transferase Pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma</article-title>. <source>Respiration</source> <volume>62</volume>, <fpage>223</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1159/000196451</pub-id><pub-id pub-id-type="pmid">8578019</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>E. R.</given-names></name> <name><surname>Keinan</surname> <given-names>S.</given-names></name> <name><surname>Mori-Sanchez</surname> <given-names>P.</given-names></name> <name><surname>Contreras-Garcia</surname> <given-names>J.</given-names></name> <name><surname>Cohen</surname> <given-names>A. J.</given-names></name> <name><surname>Yang</surname> <given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Revealing noncovalent interactions</article-title>. <source>J. Am. Chem. Soc.</source>, <volume>132</volume>, <fpage>6498</fpage>&#x02013;<lpage>6506</lpage>. <pub-id pub-id-type="doi">10.1021/ja100936w</pub-id><pub-id pub-id-type="pmid">20394428</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname> <given-names>W.</given-names></name> <name><surname>Chandrasekhar</surname> <given-names>J.</given-names></name> <name><surname>Madura</surname> <given-names>J.</given-names></name> <name><surname>Klein</surname> <given-names>M.</given-names></name></person-group> (<year>1983</year>). <article-title>Comparison of simple potential functions for simulating liquid water</article-title>. <source>J. Chem. Phys.</source> <volume>79</volume>, <fpage>926</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1063/1.445869</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karpusas</surname> <given-names>M.</given-names></name> <name><surname>Axarli</surname> <given-names>I.</given-names></name> <name><surname>Chiniadis</surname> <given-names>L.</given-names></name> <name><surname>Papakyriakou</surname> <given-names>A.</given-names></name> <name><surname>Bethanis</surname> <given-names>K.</given-names></name> <name><surname>Scopelitou</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>The interaction of the chemotherapeutic drug chlorambucil with human glutathione transferase A1-1: kinetic and structural analysis</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e56337</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0056337</pub-id><pub-id pub-id-type="pmid">23460799</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katagiri</surname> <given-names>A.</given-names></name> <name><surname>Tomita</surname> <given-names>Y.</given-names></name> <name><surname>Nishiyama</surname> <given-names>T.</given-names></name> <name><surname>Kimura</surname> <given-names>M.</given-names></name> <name><surname>Sato</surname> <given-names>S.</given-names></name></person-group> (<year>1993</year>). <article-title>Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer</article-title>. <source>Br. J. Cancer.</source> <volume>68</volume>, <fpage>125</fpage>&#x02013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.1993.299</pub-id><pub-id pub-id-type="pmid">8100442</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname> <given-names>C.-L.</given-names></name> <name><surname>Chen</surname> <given-names>S.-L.</given-names></name></person-group> (<year>2016</year>). <article-title>The Decarboxylation of &#x003B1;,&#x003B2;-Unsaturated Acid Catalyzed by Prenylated FMN-Dependent Ferulic Acid Decarboxylase and the Enzyme Inhibition</article-title>. <source>J. Org. Chem.</source> <volume>81</volume>, <fpage>9289</fpage>&#x02013;<lpage>9295</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.6b01872</pub-id><pub-id pub-id-type="pmid">27618344</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>C. T.</given-names></name> <name><surname>Yang</surname> <given-names>W. T.</given-names></name> <name><surname>Parr</surname> <given-names>R. G.</given-names></name></person-group> (<year>1988</year>). <article-title>Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density</article-title>. <source>Phys. Rev. B</source> <volume>37</volume>, <fpage>785</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1103/PhysRevB.37.785</pub-id><pub-id pub-id-type="pmid">9944570</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y.</given-names></name> <name><surname>Niu</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>B.</given-names></name> <name><surname>Edwards</surname> <given-names>H.</given-names></name> <name><surname>Xu</surname> <given-names>L.</given-names></name> <name><surname>Xie</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Synthesis and antileukemic activities of piperlongumine and HDAC inhibitor hybrids against acute myeloid leukemia cells</article-title>. <source>J. Med. Chem.</source> <volume>59</volume>, <fpage>7974</fpage>&#x02013;<lpage>7990</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b00772</pub-id><pub-id pub-id-type="pmid">27505848</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>H. W.</given-names></name> <name><surname>Ali-Osman</surname> <given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance</article-title>. <source>Curr. Opin. Pharmacol.</source> <volume>7</volume>, <fpage>367</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2007.06.009</pub-id><pub-id pub-id-type="pmid">17681492</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname> <given-names>J. A.</given-names></name> <name><surname>Martinez</surname> <given-names>C.</given-names></name> <name><surname>Kasavajhala</surname> <given-names>K.</given-names></name> <name><surname>Wickstrom</surname> <given-names>L.</given-names></name> <name><surname>Hauser</surname> <given-names>K. E.</given-names></name> <name><surname>Simemrling</surname> <given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</article-title>. <source>J. Chem. Theory Comput.</source> <volume>11</volume>, <fpage>3696</fpage>&#x02013;<lpage>3713</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.5b00255</pub-id><pub-id pub-id-type="pmid">26574453</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marenich</surname> <given-names>A. V.</given-names></name> <name><surname>Cramer</surname> <given-names>C. J.</given-names></name> <name><surname>Truhlar</surname> <given-names>D. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions</article-title>. <source>J. Phys. Chem. B</source> <volume>113</volume>, <fpage>6378</fpage>&#x02013;<lpage>6396</lpage>. <pub-id pub-id-type="doi">10.1021/jp810292n</pub-id><pub-id pub-id-type="pmid">19366259</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname> <given-names>T.</given-names></name> <name><surname>Parise</surname> <given-names>A.</given-names></name> <name><surname>Russo</surname> <given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of arsenic in the hydrolysis and DNA metalation processes in an arsenous acid&#x02013;platinum(II) anticancer complex</article-title>. <source>Phys. Chem. Chem. Phys.</source> <volume>19</volume>, <fpage>1328</fpage>&#x02013;<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1039/C6CP06179F</pub-id><pub-id pub-id-type="pmid">27966695</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McIlwain</surname> <given-names>C. C.</given-names></name> <name><surname>Townsend</surname> <given-names>D. M.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Glutathione S-transferase polymorphisms: cancer incidence and therapy</article-title>. <source>Oncogene</source> <volume>25</volume>, <fpage>1639</fpage>&#x02013;<lpage>1648</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1209373</pub-id><pub-id pub-id-type="pmid">16550164</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mejerman</surname> <given-names>I.</given-names></name> <name><surname>Beijnen</surname> <given-names>J. H.</given-names></name> <name><surname>Schellens</surname> <given-names>J. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer</article-title>. <source>Cancer Treat. Rev.</source> <volume>34</volume>, <fpage>505</fpage>&#x02013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctrv.2008.03.002</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname> <given-names>J.</given-names></name> <name><surname>Grothaus</surname> <given-names>G.</given-names></name> <name><surname>Narayanan</surname> <given-names>S.</given-names></name> <name><surname>Onufriev</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>A simple clustering algorithm can be accurate enough for use in calculations of pKs in macromolecules</article-title>. <source>Proteins</source> <volume>63</volume>, <fpage>928</fpage>&#x02013;<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1002/prot.20922</pub-id><pub-id pub-id-type="pmid">16493626</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><collab>NBO version 3.1.</collab></person-group> (<year>2001</year>).</citation></ref>
<ref id="B46">
<citation citation-type="web"><person-group person-group-type="author"><collab>NCIPLOT version 3.0.</collab></person-group> (<year>2011</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.lct.jussieu.fr/pagesperso/contrera/nciplot.html">http://www.lct.jussieu.fr/pagesperso/contrera/nciplot.html</ext-link></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname> <given-names>A. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Glutathione transferases: new functions</article-title>. <source>Curr. Opin. Struct. Biol.</source> <volume>15</volume>, <fpage>716</fpage>&#x02013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2005.10.005</pub-id><pub-id pub-id-type="pmid">16263269</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname> <given-names>A. J.</given-names></name> <name><surname>Rossjohn</surname> <given-names>J.</given-names></name> <name><surname>Lo Bello</surname> <given-names>M.</given-names></name> <name><surname>Caccuri</surname> <given-names>A. M.</given-names></name> <name><surname>Federici</surname> <given-names>G.</given-names></name> <name><surname>Parker</surname> <given-names>M. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Multifunctional role of Tyr 108 in the catalytic mechanism of human glutathione transferase P1-1. Crystallographic and kinetic studies on the Y108F mutant enzyme</article-title>. <source>Biochemistry</source> <volume>36</volume>, <fpage>576</fpage>&#x02013;<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1021/bi962813z</pub-id><pub-id pub-id-type="pmid">9166793</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okuyama</surname> <given-names>T.</given-names></name> <name><surname>Maehara</surname> <given-names>Y.</given-names></name> <name><surname>Endo</surname> <given-names>K.</given-names></name> <name><surname>Baba</surname> <given-names>H.</given-names></name> <name><surname>Adachi</surname> <given-names>Y.</given-names></name> <name><surname>Kuwano</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>1994</year>). <article-title>Expression of glutathione s-transferasepi and sensitivity of human gastric cancer cells to cisplatin</article-title>. <source>Cancer</source> <volume>74</volume>, <fpage>1230</fpage>&#x02013;<lpage>1236</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0142(19940815)74:4&#x0003C;1230::AID-CNCR2820740409&#x0003E;3.0.CO;2-0</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname> <given-names>S.</given-names></name> <name><surname>Minhajuddin</surname> <given-names>M.</given-names></name> <name><surname>Callahan</surname> <given-names>K. P.</given-names></name> <name><surname>Balys</surname> <given-names>M.</given-names></name> <name><surname>Ashton</surname> <given-names>J. M.</given-names></name> <name><surname>Neering</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume>, <fpage>33542</fpage>&#x02013;<lpage>33558</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.511170</pub-id><pub-id pub-id-type="pmid">24089526</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Meng</surname> <given-names>X.</given-names></name> <name><surname>Yao</surname> <given-names>Y.</given-names></name> <name><surname>Fang</surname> <given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents</article-title>. <source>J. Med. Chem.</source> <volume>58</volume>, <fpage>5242</fpage>&#x02013;<lpage>5255</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b00410</pub-id><pub-id pub-id-type="pmid">26079183</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perperopoulou</surname> <given-names>F.</given-names></name> <name><surname>Pouliou</surname> <given-names>F.</given-names></name> <name><surname>Labrou</surname> <given-names>N. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Recent advances in protein engineering and biotechnological applications of glutathione transferases</article-title>. <source>Crit. Rev. Biotechnol.</source> <volume>38</volume>, <fpage>511</fpage>&#x02013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1080/07388551.2017.1375890</pub-id><pub-id pub-id-type="pmid">28936894</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piazzetta</surname> <given-names>P.</given-names></name> <name><surname>Marino</surname> <given-names>T.</given-names></name> <name><surname>Russo</surname> <given-names>N.</given-names></name> <name><surname>Salahub</surname> <given-names>D. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Direct hydrogenation of carbon dioxide by an artificial reductase obtained by substituting rhodium for zinc in the carbonic anhydrase catalytic center. A mechanistic study</article-title>. <source>ACS Catal.</source> <volume>5</volume>, <fpage>5397</fpage>&#x02013;<lpage>5409</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.5b00185</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prejan&#x000F2;</surname> <given-names>M.</given-names></name> <name><surname>Marino</surname> <given-names>T.</given-names></name> <name><surname>Russo</surname> <given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>How can methanol dehydrogenase from methylacidiphilum fumariolicum work with the alien Ce<sup>III</sup> ion in the active center?</article-title> <source>A theoretical study. Chem. Eur. J.</source> <volume>23</volume>, <fpage>8652</fpage>&#x02013;<lpage>8657</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201700381</pub-id><pub-id pub-id-type="pmid">28488399</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname> <given-names>L.</given-names></name> <name><surname>Ide</surname> <given-names>T.</given-names></name> <name><surname>Gurkar</surname> <given-names>A. U.</given-names></name> <name><surname>Foley</surname> <given-names>M.</given-names></name> <name><surname>Schenone</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Selective killing of cancer cells by a small molecule targeting the stress response to ROS</article-title>. <source>Nature</source> <volume>475</volume>, <fpage>231</fpage>&#x02013;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1038/nature10167.</pub-id><pub-id pub-id-type="pmid">21753854</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritacco</surname> <given-names>I.</given-names></name> <name><surname>Russo</surname> <given-names>N.</given-names></name> <name><surname>Sicilia</surname> <given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>DFT investigation of the mechanism of action of organoiridium(III) complexes as anticancer agents</article-title>. <source>Inorg. Chem.</source> <volume>54</volume>, <fpage>10801</fpage>&#x02013;<lpage>10810</lpage>. <pub-id pub-id-type="doi">10.1021/acs.inorgchem.5b01832</pub-id><pub-id pub-id-type="pmid">26492153</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Gomez</surname> <given-names>M. J.</given-names></name> <name><surname>Souviron</surname> <given-names>A.</given-names></name> <name><surname>Martinez-Morillo</surname> <given-names>M.</given-names></name> <name><surname>Gil</surname> <given-names>L.</given-names></name></person-group> (<year>2000</year>). <article-title>P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine</article-title>. <source>J. Physiol. Biochem.</source> <volume>56</volume>, <fpage>307</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1007/BF03179798</pub-id><pub-id pub-id-type="pmid">11321524</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryckaert</surname> <given-names>J.-P.</given-names></name> <name><surname>Ciccotti</surname> <given-names>G.</given-names></name> <name><surname>Berendsen</surname> <given-names>H. J. C.</given-names></name></person-group> (<year>1977</year>). <article-title>Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes</article-title> <source>J. Comput. Phys.</source> <volume>23</volume>, <fpage>327</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9991(77)90098-5</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname> <given-names>D.</given-names></name> <name><surname>Meade</surname> <given-names>G.</given-names></name> <name><surname>Foley</surname> <given-names>V. M.</given-names></name> <name><surname>Dowd</surname> <given-names>C. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Structures, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily</article-title>. <source>Biochem. J.</source> <volume>360</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1042/bj3600001</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Siegbahn</surname> <given-names>P. E. M.</given-names></name> <name><surname>Himo</surname> <given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>The quantum chemical cluster approach for modeling enzyme reactions</article-title>. <source>Wiley Interdiscip. Rev: Comput. Mol. Sci.</source> <volume>1</volume>, <fpage>323</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1002/wcms.13</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname> <given-names>S. F. M</given-names></name> <name><surname>Ribeiro</surname> <given-names>A. J.</given-names></name> <name><surname>Neves</surname> <given-names>R. R. P.</given-names></name> <name><surname>Br&#x000E1;s</surname> <given-names>N. F.</given-names></name> <name><surname>Cerqueira</surname> <given-names>N. M. F. S. A.</given-names></name> <name><surname>Ramos</surname> <given-names>M. J.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Application of quantum mechanics/molecular mechanics methods in the study of enzymatic reaction mechanisms</article-title>. <source>WIREs Comput. Mol. Sci.</source> <volume>7</volume>, <fpage>e1281</fpage>&#x02013;<lpage>1311</lpage>. <pub-id pub-id-type="doi">10.1002/wcms.1281</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoddard</surname> <given-names>E. G.</given-names></name> <name><surname>Killinger</surname> <given-names>B. J.</given-names></name> <name><surname>Nair</surname> <given-names>R. N.</given-names></name> <name><surname>Sadler</surname> <given-names>N. C.</given-names></name> <name><surname>Volk</surname> <given-names>R. F.</given-names></name> <name><surname>Purvine</surname> <given-names>S. O.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Activity-based probes for isoenzyme- and site-specific functional characterization of glutathione S-transferases</article-title>. <source>J. Am. Chem. Soc.</source> <volume>139</volume>, <fpage>16032</fpage>&#x02013;<lpage>16035</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b07378</pub-id><pub-id pub-id-type="pmid">29068682</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname> <given-names>M.</given-names></name> <name><surname>Humbel</surname> <given-names>S.</given-names></name> <name><surname>Froese</surname> <given-names>R. D. J.</given-names></name> <name><surname>Matsubara</surname> <given-names>T.</given-names></name> <name><surname>Sieber</surname> <given-names>S.</given-names></name> <name><surname>Morokuma</surname> <given-names>K.</given-names></name></person-group> (<year>1996</year>). <article-title>ONIOM: a multilayered integrated MO &#x0002B; MM method for geometry optimizations and single point energy predictions. a test for diels&#x02013;alder reactions and Pt(P(t-Bu)<sub>3</sub>)<sub>2</sub> &#x0002B; H<sub>2</sub> oxidative addition</article-title>. <source>J. Phys. Chem.</source> <volume>100</volume>, <fpage>19357</fpage>&#x02013;<lpage>19363</lpage>. <pub-id pub-id-type="doi">10.1021/jp962071j</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tew</surname> <given-names>K. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation</article-title>. <source>Biochem. Pharmacol.</source> <volume>73</volume>, <fpage>1257</fpage>&#x02013;<lpage>1269</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2006.09.027</pub-id><pub-id pub-id-type="pmid">17098212</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname> <given-names>D. M.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name></person-group> (<year>2003</year>). <article-title>The role of glutathione-S-transferase in anti-cancer drug resistance</article-title>. <source>Oncogene</source> <volume>22</volume>, <fpage>7369</fpage>&#x02013;<lpage>7375</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206940</pub-id><pub-id pub-id-type="pmid">14576844</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vreven</surname> <given-names>T.</given-names></name> <name><surname>Byun</surname> <given-names>K. S.</given-names></name> <name><surname>Kom&#x000E1;romi</surname> <given-names>I.</given-names></name> <name><surname>Dapprich</surname> <given-names>S.</given-names></name> <name><surname>Montgomery</surname> <given-names>J. A.</given-names> <suffix>Jr.</suffix></name> <name><surname>Morokuma</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Combining quantum mechanics methods with molecular mechanics methods in ONIOM</article-title>. <source>J. Chem. Theory Comput.</source> <volume>2</volume>, <fpage>815</fpage>&#x02013;<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1021/ct050289g</pub-id><pub-id pub-id-type="pmid">26626688</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H. B.</given-names></name> <name><surname>Jin</surname> <given-names>X. L.</given-names></name> <name><surname>Zheng</surname> <given-names>J. F.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <name><surname>Dai</surname> <given-names>F.</given-names></name> <name><surname>Zhou</surname> <given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Developing piperlongumine-directed glutathione S-transferase inhibitors by an electrophilicity-based strategy</article-title>. <source>Eur. J. Med. Chem.</source> <volume>126</volume>, <fpage>517</fpage>&#x02013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.11.034</pub-id><pub-id pub-id-type="pmid">27914365</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Wolf</surname> <given-names>R. M.</given-names></name> <name><surname>Caldwell</surname> <given-names>J. W.</given-names></name> <name><surname>Kollman</surname> <given-names>P. A.</given-names></name> <name><surname>Case</surname> <given-names>D. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Development and testing of a general amber force field</article-title>. <source>J. Comp. Chem.</source> <volume>25</volume>, <fpage>1157</fpage>&#x02013;<lpage>1173</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20035</pub-id><pub-id pub-id-type="pmid">15116359</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>T.</given-names></name> <name><surname>Arifoglu</surname> <given-names>P.</given-names></name> <name><surname>Ronai</surname> <given-names>Z.</given-names></name> <name><surname>Tew</surname> <given-names>K. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Glutathione S-transferase P1&#x02013;1 (GSTP1&#x02013;1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>20999</fpage>&#x02013;<lpage>21003</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101355200</pub-id><pub-id pub-id-type="pmid">11279197</pub-id></citation></ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilce</surname> <given-names>M. C.</given-names></name> <name><surname>Parker</surname> <given-names>M. W.</given-names></name></person-group> (<year>1994</year>). <article-title>Structure and function of glutathione S-transferases</article-title>. <source>Biochim. Biophys. Acta Protein Struct. Mol. Enzymol.</source> <volume>1205</volume>, <fpage>1</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/0167-4838(94)90086-8</pub-id><pub-id pub-id-type="pmid">8142473</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Xiao</surname> <given-names>Y.</given-names></name> <name><surname>Priddy</surname> <given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Increase in placental glutathione S-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas</article-title>. <source>J. Oral. Pathol. Med.</source> <volume>23</volume>, <fpage>75</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0714.1994.tb00260.x</pub-id><pub-id pub-id-type="pmid">8164157</pub-id></citation></ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>Y.-J.</given-names></name> <name><surname>Ornstein</surname> <given-names>R.: L.</given-names></name></person-group> (<year>1997</year>). <article-title>Role of active site tyrosine in glutathione S-transferase: insights from a theoretical study on model systems</article-title>. <source>J. Am. Chem. Soc.</source> <volume>1997</volume>, <fpage>1523</fpage>&#x02013;<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1021/ja961667h</pub-id></citation></ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>D.</given-names></name> <name><surname>Yan</surname> <given-names>C.</given-names></name> <name><surname>Ji</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>J. Med. Chem.</source> <volume>61</volume>, <fpage>1821</fpage>&#x02013;<lpage>1832</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b01096</pub-id><pub-id pub-id-type="pmid">29424539</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> Financial support from the Universit&#x000E0; degli Studi della Calabria-Dipartimento di Chimica e Tecnologie Chimiche (CTC) is acknowledged.</p></fn>
</fn-group>
</back>
</article>